All stock lists
Penumbra Inc (PEN)
United States · Delayed Price · Currency is USD
Surgical & Medical Instruments & Apparatus
324.82+0.44 (+0.13%)
Insider Score
––Not scored
PEN Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
PEN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 390.05 M | 374.76 M | 385.38 M | 354.69 M | 339.45 M |
| Revenue Growth (YoY) | 14.90 % | — | — | — | — |
| Cost of Revenue | 125.10 M | 121.35 M | 123.26 M | 114.27 M | 115.44 M |
| Gross Profit | 264.94 M | 253.41 M | 262.13 M | 240.42 M | 224.01 M |
| SG&A Expense | 198.51 M | 192.79 M | 181.10 M | 168.90 M | 159.96 M |
| R&D Expense | 25.40 M | 22.38 M | 21.79 M | 22.68 M | 23.22 M |
| Operating Expenses | 223.91 M | 215.18 M | 202.90 M | 191.58 M | 183.18 M |
| Operating Income | 41.04 M | 38.23 M | 59.23 M | 48.84 M | 40.83 M |
| Pretax Income | 46.19 M | 41.69 M | 63.63 M | 52.33 M | 45.31 M |
| Tax Provision | 11.38 M | 9.10 M | 16.29 M | 6.47 M | 40.00 K |
| Net Income | 34.81 M | 32.58 M | 47.34 M | 45.85 M | 45.27 M |
| EPS (Basic) | 0.88 | 0.83 | 1.21 | 1.17 | 1.15 |
| EPS (Diluted) | 0.88 | 0.82 | 1.20 | 1.17 | 1.15 |
| Shares Outstanding | 39.35 M | 39.28 M | 39.19 M | 39.08 M | 38.83 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.